High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study

MeSH terms

• Aged
• Aged, 80 and over
• Antimetabolites, Antineoplastic / therapeutic use
• Azacitidine / therapeutic use*
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Female
• Humans
• Italy
• Leukemia, Myelomonocytic, Chronic / drug therapy*
• Male
• Middle Aged
• Prognosis
• Remission Induction
• Retrospective Studies
• Survival Analysis
• Time Factors
• Treatment Outcome